SuperSaturated Oxygen (SSO2) Therapy is a novel treatment designed to minimize myocardial damage in anterior LAD STEMI patients treated within 6 hours of symptom onset. SSO2 Therapy restores microvascular flow, improves left ventricular function and significantly reduces infarct size.